Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-25-004810

Chief Scientific Officer sold 96,656 shares at an average $6.99 ($675,219)

  • Chief Scientific Officer acquired 355,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

ROBINS HARLAN S · Chief Scientific Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-03-04 Grant or award : show line 1 in the form +355,000 1,376,180 D
2025-03-05 Sale : show line 2 in the form −40,603 $6.98 $283,409 1,335,577 D
2025-03-05 Sale : show line 3 in the form −56,053 $6.99 $391,810 1,279,524 D
Open-market sales · 96,656 sh · avg $6.99 · $675,219
Loading xslF345X05/form4.xml…